This page lists the SEC filings reported by STONEPINE CAPITAL, L.P..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2016-02-12 | STONEPINE CAPITAL, L.P. | AMARIN CORP PLC\UK | 0 | 0.0% | EDGAR |
| SC 13G | 2015-08-31 | STONEPINE CAPITAL, L.P. | PERNIX THERAPEUTICS HOLDINGS, INC. | 3,324,006 | 5.4% | EDGAR |
| SC 13G | 2015-05-29 | STONEPINE CAPITAL, L.P. | Aegerion Pharmaceuticals, Inc. | 1,500,000 | 5.2% | EDGAR |
| SC 13D | 2015-05-21 | STONEPINE CAPITAL, L.P. | VIVEVE MEDICAL, INC. | 15,540,540 | 30.6% | EDGAR |
| SC 13G | 2015-03-09 | STONEPINE CAPITAL L P | PHOTOMEDEX INC | 1,206,789 | 5.9% | EDGAR |
| SC 13G/A | 2015-02-09 | STONEPINE CAPITAL L P | AMARIN CORP PLC\UK | 11,334,295 | 6.5% | EDGAR |
| SC 13G/A | 2015-02-06 | STONEPINE CAPITAL L P | SCICLONE PHARMACEUTICALS INC | 312,000 | 0.6% | EDGAR |
| SC 13G/A | 2015-02-06 | STONEPINE CAPITAL L P | Vericel Corp | 1,789,118 | 7.5% | EDGAR |
| SC 13G/A | 2015-02-06 | STONEPINE CAPITAL L P | ENZON PHARMACEUTICALS INC | 3,401,783 | 7.7% | EDGAR |
| SC 13G/A | 2015-02-06 | STONEPINE CAPITAL L P | Regado Biosciences Inc | 3,557,360 | 10.0% | EDGAR |
| SC 13G/A | 2015-02-06 | STONEPINE CAPITAL L P | PAIN THERAPEUTICS INC | 3,133,739 | 6.8% | EDGAR |
| SC 13G/A | 2015-02-06 | STONEPINE CAPITAL L P | AMARIN CORP PLC | 11,334,295 | 6.5% | EDGAR |
| SC 13G | 2014-11-26 | STONEPINE CAPITAL L P | Regado Biosciences Inc | 1,954,621 | 5.8% | EDGAR |
| SC 13G | 2014-11-19 | STONEPINE CAPITAL L P | AMARIN CORP PLC\UK | 9,000,000 | 5.2% | EDGAR |
| SC 13G | 2014-11-10 | STONEPINE CAPITAL L P | PAIN THERAPEUTICS INC | 2,791,881 | 6.1% | EDGAR |
| SC 13G | 2014-09-22 | STONEPINE CAPITAL L P | AASTROM BIOSCIENCES INC | 1,700,000 | 7.1% | EDGAR |
| SC 13D/A | 2014-06-30 | STONEPINE CAPITAL L P | BIOSPECIFICS TECHNOLOGIES CORP | 319,009 | 4.9% | EDGAR |
| SC 13G | 2014-04-04 | STONEPINE CAPITAL L P | SCICLONE PHARMACEUTICALS INC | 2,013,636 | 3.8% | EDGAR |
| SC 13G | 2014-03-13 | STONEPINE CAPITAL L P | ENZON PHARMACEUTICALS INC | 4,200,000 | 9.5% | EDGAR |
| SC 13D | 2014-03-07 | STONEPINE CAPITAL L P | BIOSPECIFICS TECHNOLOGIES CORP | 405,000 | 6.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.